0.555
price up icon0.00%   0.00
 
loading
Zynex Inc stock is traded at $0.555, with a volume of 2.36M. It is up +0.00% in the last 24 hours and down -59.34% over the past month. Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
See More
Previous Close:
$0.555
Open:
$0.5389
24h Volume:
2.36M
Relative Volume:
1.36
Market Cap:
$14.09M
Revenue:
$144.81M
Net Income/Loss:
$-28.66M
P/E Ratio:
-0.5928
EPS:
-0.9362
Net Cash Flow:
$-7.67M
1W Performance:
-28.72%
1M Performance:
-59.34%
6M Performance:
-77.53%
1Y Performance:
-92.94%
1-Day Range:
Value
$0.45
$0.5777
1-Week Range:
Value
$0.3759
$0.7786
52-Week Range:
Value
$0.3759
$8.72

Zynex Inc Stock (ZYXI) Company Profile

Name
Name
Zynex Inc
Name
Phone
(800)-495-6670
Name
Address
9655 MAROON CIRCLE, ENGLEWOOD, CO
Name
Employee
1,000
Name
Twitter
@zynexmedical
Name
Next Earnings Date
2025-10-31
Name
Latest SEC Filings
Name
ZYXI's Discussions on Twitter

Compare ZYXI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
9.30 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
2.41 2.92B 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
19.75 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
4.06 178.28M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.212 423.86M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
0.8073 0 0 0 0 0.00

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-01-25 Downgrade H.C. Wainwright Buy → Neutral
Aug-01-25 Upgrade Ladenburg Thalmann Neutral → Buy
Mar-12-25 Downgrade Ladenburg Thalmann Buy → Neutral
Mar-12-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Oct-16-23 Initiated RBC Capital Mkts Outperform
Jan-06-23 Upgrade Piper Sandler Neutral → Overweight
Feb-28-22 Reiterated B. Riley Securities Buy
Jul-16-21 Upgrade B. Riley Securities Neutral → Buy
Mar-09-21 Upgrade Northland Capital Market Perform → Outperform
Feb-26-21 Downgrade B. Riley Securities Buy → Neutral
Jan-29-21 Downgrade Piper Sandler Overweight → Neutral
Jan-28-21 Downgrade Northland Capital Outperform → Market Perform
Sep-14-20 Upgrade H.C. Wainwright Neutral → Buy
Sep-09-20 Upgrade Northland Capital Market Perform → Outperform
Jul-29-20 Upgrade B. Riley FBR Neutral → Buy
Jul-20-20 Initiated Piper Sandler Overweight
Jul-13-20 Downgrade B. Riley FBR Buy → Neutral
Jul-10-20 Reiterated H.C. Wainwright Neutral
Jun-16-20 Downgrade Northland Capital Outperform → Market Perform
May-19-20 Downgrade H.C. Wainwright Buy → Neutral
Apr-01-20 Initiated Northland Capital Outperform
Sep-23-19 Initiated H.C. Wainwright Buy
View All

Zynex Inc Stock (ZYXI) Latest News

pulisher
07:00 AM

How Zynex Inc. stock reacts to job market dataPortfolio Risk Summary & Stock Portfolio Risk Management - newser.com

07:00 AM
pulisher
06:29 AM

Is Zynex Inc. stock a good choice for value investorsEarnings Risk Report & Free Community Supported Trade Ideas - newser.com

06:29 AM
pulisher
05:48 AM

Zynex Inc. Earnings Call: Financial Challenges and Strategic Initiatives - The Globe and Mail

05:48 AM
pulisher
02:30 AM

What technical signals suggest for Zynex Inc. stock2025 Market WrapUp & Community Trade Idea Sharing - newser.com

02:30 AM
pulisher
Nov 19, 2025

Earnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours - Nasdaq

Nov 19, 2025
pulisher
Nov 19, 2025

What candlestick patterns are forming on Zynex Inc.2025 Support & Resistance & Reliable Breakout Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to integrate Zynex Inc. into portfolio analysis tools2025 Investor Takeaways & Target Return Focused Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Zynex Inc. stock double in next 5 years2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Zynex Inc. stock could outperform in 2025Forecast Cut & Growth-Oriented Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Analyzing drawdowns of Zynex Inc. with statistical toolsM&A Rumor & AI Driven Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Zynex Inc. stock could rally in 20252025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Zynex, Inc. (NASDAQ:ZYXI) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 19, 2025
pulisher
Nov 19, 2025

Detecting support and resistance levels for Zynex Inc.Weekly Trade Review & Verified Short-Term Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Zynex Inc. Faces Legal and Regulatory Turmoil: Potential Impact on Financial Health and Operations - TipRanks

Nov 19, 2025
pulisher
Nov 19, 2025

Volume spikes in Zynex Inc. stock – what they meanJuly 2025 Highlights & Consistent Growth Equity Picks - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Zynex Faces Financial Challenges Amid Revenue Decline - TipRanks

Nov 18, 2025
pulisher
Nov 18, 2025

Zynex Inc (ZYXI) Q3 2025 Earnings Call Highlights: Navigating Financial Challenges Amid ... - Yahoo Finance

Nov 18, 2025
pulisher
Nov 18, 2025

Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 18, 2025
pulisher
Nov 18, 2025

Earnings call transcript: Zynex Q3 2025 results miss forecasts, stock tumbles - Investing.com Nigeria

Nov 18, 2025
pulisher
Nov 18, 2025

Zynex Q3 2025 Earnings Call Transcript - MarketBeat

Nov 18, 2025
pulisher
Nov 17, 2025

Zynex Reports Third Quarter 2025 Financial Results - The Malaysian Reserve

Nov 17, 2025
pulisher
Nov 17, 2025

Medical device firm Zynex's Q3 revenue misses expectations - TradingView

Nov 17, 2025
pulisher
Nov 17, 2025

ZYNEX INC SEC 10-Q Report - TradingView

Nov 17, 2025
pulisher
Nov 17, 2025

ZYXI: Severe revenue drop and $42.9M net loss in Q3 2025 amid payment suspensions and restructuring - TradingView

Nov 17, 2025
pulisher
Nov 17, 2025

Zynex (NASDAQ: ZYXI) posts Q3 net loss of $42.9M and engages Province for strategic review - Stock Titan

Nov 17, 2025
pulisher
Nov 17, 2025

Earnings Outlook For Zynex - Benzinga

Nov 17, 2025
pulisher
Nov 17, 2025

Is Zynex Inc. stock ready for a breakoutPortfolio Performance Summary & Short-Term High Return Ideas - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Will Zynex Inc. stock rally after Fed decisionsTrade Analysis Summary & Real-Time Price Movement Reports - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is Zynex Inc a good long term investmentGap Up/Gap Down Analysis & Free Phenomenal Capital Appreciation - earlytimes.in

Nov 16, 2025
pulisher
Nov 16, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Zynex, Inc. (ZYXI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Nov 16, 2025
pulisher
Nov 16, 2025

Is Zynex Inc. stock a safe investment in uncertain marketsWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Zynex announces series of strategic initiatives, to evaluate alternatives - Yahoo Finance

Nov 15, 2025
pulisher
Nov 14, 2025

Zynex Sets Third Quarter 2025 Earnings Call - 富途牛牛

Nov 14, 2025
pulisher
Nov 14, 2025

Zynex stock tumbles as company explores strategic alternatives By Investing.com - Investing.com UK

Nov 14, 2025

Zynex Inc Stock (ZYXI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Zynex Inc Stock (ZYXI) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
MOORHEAD DANIEL J
CHIEF FINANCIAL OFFICER
Feb 03 '25
Sale
7.68
10,000
76,800
19,738
$0.6425
price up icon 0.14%
$2.35
price up icon 0.00%
$2.3101
price up icon 4.93%
$2.215
price up icon 0.00%
medical_distribution OMI
$2.72
price down icon 0.55%
medical_distribution AHG
$1.53
price up icon 0.42%
Cap:     |  Volume (24h):